Krishak Biotech
Krishak Biotech is a Private Indian company incorporated in 2008 and based in Maharashtra, India. Krishak Biotech operates in Pharmaceuticals & Chemicals (NIC 24210) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
Krishak Biotech - Manufactures and supplies agrochemicals. This company is not active anymore.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Krishak Biotech.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 21 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 21 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +39d | filed |
| MGT-7 | FY2022-23 | 21 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Krishak Biotech.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 485506460 | State Bank of India(Bank) | ₹12.48 Cr | 27 Jan 2020 | Open |
| 957470601 | ICICI Bank Ltd(Bank) | ₹1.38 Cr | 12 Mar 2023 | Satisfied |
| 666040602 | Axis Bank Ltd(Bank) | ₹2.22 Cr | 19 Sep 2023 | Satisfied |
| 580657365 | Axis Bank Ltd(Bank) | ₹24.66 Cr | 12 Mar 2022 | Open |
| 796452123 | HDFC Bank Ltd(Bank) | ₹10.92 Cr | 19 Sep 2019 | Satisfied |
| 758847751 | State Bank of India(Bank) | ₹10.23 Cr | 19 Sep 2022 | Satisfied |
Charge IDs, lenders & amounts for Krishak Biotech.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹64.06 Cr | ₹27.86 L | ₹42.41 Cr | ₹102.30 Cr | 350 |
| FY2023-24 | ₹53.33 Cr | ₹1.06 Cr | ₹33.39 Cr | ₹62.87 Cr | 157 |
| FY2022-23 | ₹48.84 Cr | ₹53.48 L | ₹45.70 Cr | ₹82.74 Cr | 190 |
| FY2021-22 | ₹37.01 Cr | ₹70.17 L | ₹37.41 Cr | ₹58.41 Cr | 109 |
Audited financials & ratios for Krishak Biotech.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹64.06 Cr | ₹53.33 Cr | ₹48.84 Cr | ₹37.01 Cr |
| Other income | ₹1.56 Cr | ₹34.54 L | ₹1.85 Cr | ₹48.50 L |
| Total income | ₹65.62 Cr | ₹53.67 Cr | ₹50.69 Cr | ₹37.49 Cr |
| Total expenses | ₹65.26 Cr | ₹52.32 Cr | ₹50.00 Cr | ₹36.59 Cr |
| Profit before tax | ₹36.22 L | ₹1.37 Cr | ₹69.52 L | ₹91.22 L |
| Profit / (Loss) after tax | ₹27.86 L | ₹1.06 Cr | ₹53.48 L | ₹70.17 L |
| Balance sheet | ||||
| Equity / Net worth | ₹42.41 Cr | ₹33.39 Cr | ₹45.70 Cr | ₹37.41 Cr |
| Borrowings | ₹30.83 Cr | ₹8.96 Cr | ₹10.61 Cr | ₹8.52 Cr |
| Current liabilities | ₹34.02 Cr | ₹14.75 Cr | ₹17.66 Cr | ₹8.94 Cr |
| Total liabilities | ₹59.89 Cr | ₹29.48 Cr | ₹37.04 Cr | ₹21.00 Cr |
| Current assets | ₹52.41 Cr | ₹22.67 Cr | ₹47.98 Cr | ₹31.33 Cr |
| Cash & equivalents | ₹19.34 Cr | ₹8.92 Cr | ₹9.60 Cr | ₹10.63 Cr |
| Total assets | ₹102.30 Cr | ₹62.87 Cr | ₹82.74 Cr | ₹58.41 Cr |
| Employees | 350 | 157 | 190 | 109 |
Audited financials & ratios for Krishak Biotech.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹64.06 Cr | +14.1% | +16.0% | -1.7% |
| Profit after Tax | ₹27.86 L | +25.2% | +23.5% | +2.6% |
| Net Worth | ₹42.41 Cr | +23.6% | +0.5% | +3.9% |
| Employees | 350 | +34.3% | -2.5% | +0.7% |
Audited financials & ratios for Krishak Biotech.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹64.06 Cr | ₹27.86 L | +0.43% | -1.02% | +0.66% | +0.27% | 0.73 | ₹18.30 L |
| FY2023-24 | ₹53.33 Cr | ₹1.06 Cr | +1.98% | -0.99% | +3.17% | +1.68% | 0.27 | ₹33.97 L |
| FY2022-23 | ₹48.84 Cr | ₹53.48 L | +1.10% | +10.51% | +1.17% | +0.65% | 0.23 | ₹25.70 L |
| FY2021-22 | ₹37.01 Cr | ₹70.17 L | +1.90% | +18.72% | +1.88% | +1.20% | 0.23 | ₹33.95 L |
Audited financials & ratios for Krishak Biotech.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 2,33,89,869 | 56.33% |
| Institutional Investors | 3 | 58,96,058 | 14.20% |
| Public & Others | 22 | 1,22,36,413 | 29.47% |
Promoter, institutional & public holding for Krishak Biotech.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
100 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.